Navigation Links
Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
Date:7/19/2013

New York, NY (PRWEB) July 19, 2013

On July 19, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the discovery of a Nano drug, SapC-DOPS, that may aid in treating brain tumors.

According to a July 17, 2013 article published on MedicalXpress.com entitled “Nano drug crosses blood-brain tumor barrier, targets brain tumor cells and blood vessels,” a recent animal and laboratory study conducted by researchers at the Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and the Richard J. Solove Research Institute, showed that an “experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels.” These findings support further development of the drug as a “novel treatment for brain tumors.”

With 3,470 new brain tumor cases in the United States expected this year and a median survival rate of about 15 months, glioblastoma multiforme is the most common and aggressive form of brain cancer. One of the major obstacles obstructing effective treatment of this disease is the blood-brain barrier which is the tight fit of cells that make up the blood vessels in the brain. It protects the brain from toxins in the blood but also keeps drugs in the bloodstream from reaching the brain tumors.

“Few drugs have the capacity to cross the tumor blood-brain barrier and specifically target tumor cells,” says principal investigator on the study, Balveen Kaur, PhD and associate professor of neurological surgery and chief of the Dardinger Laboratory of Neurosciences at the OSUCCC-James. “Our preclinical study indicates that SapC-DOPS does both and inhibits the growth of new tumor blood vessels, suggesting that this agent could one day be an important treatment for glioblastoma and other solid tumors.”

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the recent discovery. “Every single day, we hear of new scientific discoveries being made for brain cancer treatment. It gives us and the rest of the brain cancer community hope that one day this horrible disease will be cured. Hats off to Dr. Kaur and his team for their continuous efforts.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations
###

Read the full story at http://www.prweb.com/releases/2013/7/prweb10942215.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Commends Neuropsychologist and Team for Research on Cognitive Brain-Training for Cancer Survivors
2. Voices Against Brain Cancer Comments on Discovery of a Cause of Resistance to Therapy in Cases of Brain Cancer
3. Voices Against Brain Cancer Comments on Recent Discovery in Ongoing Brain Cancer Research
4. Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
5. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
6. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
7. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
8. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
9. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
10. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
11. Avatar therapy helps silence voices in schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... arrival of Sovaldi, which made headlines mostly for its cost despite its potential ... and moral questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have ...
(Date:5/6/2016)... ... 2016 , ... RowdMap, Inc. co-founder, Joshua Rosenthal, PhD, joins ... Deputy Administrator at Centers for Medicare and Medicaid Services (CMS); Ali Khan, MD, ... Officer at Health Care Service Corporation (Blue Cross and Blue Shield of Illinois, ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... the Responsible Wool Standard (RWS) for public stakeholder review. The stakeholder review is an ... that it meets its goals and delivers value to the wool industry., The RWS ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... This weekend, from Friday, May 6 - ... on steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in ... will be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
Breaking Medicine Technology: